BUYINS.NET Issues Hemispherx Biopharma SqueezeTrigger Report; Over 26 Million Shares Shorted in 2009; Next Short Squeeze Expected Above $1.13
NEWPORT BEACH, Calif., Nov 23, 2009 (GlobeNewswire via COMTEX) -- By Staff
Company: Hemispherx BioPharma, Inc. (HEB)
BUYINS.NET, www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Hemispherx Biopharma (AMEX:HEB) after releasing the latest short sale data to November 20, 2009. From January 2005 to November 2009 approximately 1.39 billion total aggregate shares of HEB have traded for a total dollar value of nearly $2.97 billion. The total aggregate number of shares shorted in this time period is approximately 75.5 million shares. There have been nearly 26 million shares shorted in 2009 alone. The next short squeeze is expected to begin when shares of HEB close above $1.13, where over 2.8 million shares have been shorted. The following chart shows the monthly SqueezeTrigger levels where short sellers go out-of-the-money on their trades and are most likely to start covering.
http://www.buyins.com/images/hebstr11-20-09.jpg
A detailed HEB report is at: http://www.buyins.com/reports/heb11-19-09.pdf
BUYINS.NET will investigate all trading in Hemispherx Biopharma, the market makers the trades transacted through and the source of those trades. This surveillance is to ascertain if a fair market is being made and whether or not traders are complying with all regulatory requirements of Regulation SHO. Results of this investigation will be reported to the appropriate regulatory agencies.
The following chart identifies trades and their corresponding market makers from 1-1-09 to 11-20-09. Click here to view trade data:
http://www.buyins.com/images/hebmm11-20-09.jpg
About BUYINS.NET
BUYINS.NET, www.buyins.net, monitors trading in all U.S. stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all U.S. stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 27 billion cell database tracks EVERY short sale (not just total short interest) in all U.S. stocks and calculates volume weighted price that a short squeeze will begin in each stock
Earnings Edge -- predicts probability, price move and length of move before and after all U.S. stock earnings reports
Seasonality -- predicts probability, price move and length of move based on exact time of year for all U.S. stocks
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. The company has paid $995 per month to purchase data for information provided in twelve monthly reports. Please read our report and visit our web site, www.buyins.net, for complete risks and disclosures.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: BUYINS.NET
CONTACT: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net
Copyright (C) 2009 GlobeNewswire. All rights reserved
News Provided by COMTEX
Company: Hemispherx BioPharma, Inc. (HEB)
Related terms: advisor, amex, dollar, earnings, hedge fund, investigation, investment, investment opinion, market, prices, sales, securities, security, statistics, trade, web
